These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33207264)

  • 1. Rescue of NanoLuc luciferase-expressing Senecavirus A with oncolytic activity.
    Liu F; Wang Q; Huang Y; Wang N; Shan H
    Virus Res; 2021 Jan; 292():198232. PubMed ID: 33207264
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kanai Y; Kawagishi T; Matsuura Y; Kobayashi T
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious recombinant Senecavirus A expressing novel reporter proteins.
    Wang M; Mou C; Chen M; Chen Z
    Appl Microbiol Biotechnol; 2021 Mar; 105(6):2385-2397. PubMed ID: 33660038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of eGFP-Tagged Senecavirus A for Facilitating Virus Neutralization Test and Antiviral Assay.
    Liu F; Huang Y; Wang Q; Shan H
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32150804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and Generation of a Recombinant Senecavirus a Stably Expressing the NanoLuc Luciferase for Quantitative Antiviral Assay.
    Guo X; Zhao K; Liu X; Lei B; Zhang W; Li X; Yuan W
    Front Microbiol; 2021; 12():745502. PubMed ID: 34659180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious Recombinant Senecavirus A Expressing p16
    Gong W; Zhao X; Tang X; Gao L; Sun Y; Ma J
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of a recombinant Senecavirus A expressing enhanced green fluorescent protein.
    Huang W; Chen Y; Xu T; Xiong T; Lv Y; Liu D; Chen R
    Front Microbiol; 2024; 15():1443696. PubMed ID: 39391602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of recombinant senecavirus A expressing secreted luciferase for antiviral screening.
    Wang H; Mo Y; Liu W; He Q; Ren T; Ouyang K; Chen Y; Huang W; Wei Z
    J Virol Methods; 2024 Jun; 327():114932. PubMed ID: 38582378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for
    Utrilla-Trigo S; Jiménez-Cabello L; Marín-López A; Illescas-Amo M; Andrés G; Calvo-Pinilla E; Lorenzo G; van Rijn PA; Ortego J; Nogales A
    Microbiol Spectr; 2024 Mar; 12(3):e0249323. PubMed ID: 38353566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A virulent and pathogenic infectious clone of Senecavirus A.
    Fernandes MHV; de Lima M; Joshi LR; Diel DG
    J Gen Virol; 2021 Aug; 102(8):. PubMed ID: 34424160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.
    Wei D; Sun N; Nan G; Wang Y; Liu HQ; Peeters B; Chen ZN; Bian H
    Hum Gene Ther; 2012 Jul; 23(7):700-10. PubMed ID: 22372930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.
    Guse K; Dias JD; Bauerschmitz GJ; Hakkarainen T; Aavik E; Ranki T; Pisto T; Särkioja M; Desmond RA; Kanerva A; Hemminki A
    Gene Ther; 2007 Jun; 14(11):902-11. PubMed ID: 17377596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001.
    Poirier JT; Reddy PS; Idamakanti N; Li SS; Stump KL; Burroughs KD; Hallenbeck PL; Rudin CM
    J Gen Virol; 2012 Dec; 93(Pt 12):2606-2613. PubMed ID: 22971818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo infection of live tissue with oncolytic viruses.
    Diallo JS; Roy D; Abdelbary H; De Silva N; Bell JC
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
    Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
    J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of NanoLuc Luciferase-Tagged Canine Distemper Virus for Facilitating Rapid Screening of Antivirals
    Liu F; Wang Q; Huang Y; Wang N; Zhang Y; Shan H
    Front Vet Sci; 2020; 7():600796. PubMed ID: 33363240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of Senecavirus A to uncover mutation profiles of its progenies during 80 serial passages in vitro.
    Liu F; Huang Y; Wang Q; Li J; Shan H
    Vet Microbiol; 2021 Feb; 253():108969. PubMed ID: 33450657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A slow but steady nanoLuc: R162A mutation results in a decreased, but stable, nanoLuc activity.
    Ahmed WS; Geethakumari AM; Sultana A; Fatima A; Philip AM; Uddin SMN; Biswas KH
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131864. PubMed ID: 38692549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senecavirus A 2B protein suppresses type I interferon production by inducing the degradation of MAVS.
    Liu H; Li K; Chen W; Yang F; Cao W; Zhang K; Li P; Tang L; Zhu Z; Zheng H
    Mol Immunol; 2022 Feb; 142():11-21. PubMed ID: 34959069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insert Stability and In Vivo Testing of MicroRNA-Detargeted Oncolytic Picornaviruses.
    Schulze AJ
    Methods Mol Biol; 2020; 2058():77-94. PubMed ID: 31486032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.